Table 2.
Observed vs. predicted average QT intervals
| QT interval [ms] | |||||
|---|---|---|---|---|---|
| Observed | Predicted suma | Predicted Blissa | Predicted Loewea | ||
| Fluoxetine [1] | BL | 372.4 | 396.0 | ||
| T | 374.9 | 398.5 | |||
| I | – | 400.9 | |||
| T + I | 379 | 401.6 | 400.8 | 400.2 | |
| Distance | 1.49 | 2.59 | 3.34 | ||
| Erythromycin [15] | BL | 392.8 | |||
| T2 | 8 | 398.5 | |||
| Ib | 21 | 403.7 | |||
| T + Ib | 39 | 418.2 | 413.6 | 411.4 | |
| Distance | 18.38 | 22.75 | 25.13 | ||
| Fluconazole [16] | BL | 398.5 | 395.2 | ||
| T | 398.4 | 401.3 | |||
| I | 414.3 | ||||
| T + I | 411 | 422.6 | 418.6 | 416.8 | |
| Distance | 31.28 | 26.02 | 23.65 | ||
| Itraconazolec [17] | BL | 376 | 430.5 | ||
| T | 390 | 438 | |||
| I | No effect | 486.9 | |||
| T + I | 417 | 452.2 | 448.9 | 447.3 | |
| Distance | 24.05 | 28.50 | 30.68 | ||
| Ketoconazole [18] | BL | 408 | 394.5 | ||
| T | 416 | 395 | |||
| I | – | 415.4 | |||
| T + I | 490 | 439 | 427.9 | 423.6 | |
| Distance | 48.61 | 64.03 | 70.14 | ||
| Clarithromycin [19] | BL | 409 | 395.5 | ||
| T | 410 | 401.4 | |||
| I | 407 | 393.9 | |||
| T + I | 430 | 404.4 | 403.8 | 402.7 | |
| Distance | 21.43 | 22.96 | 23.79 | ||
| Erythromycin [19] | BL | 394 | 397.5 | ||
| T | 408 | 403.7 | |||
| I | 409 | 405.8 | |||
| T + I | 428 | 420.1 | 415.6 | 413.5 | |
| Distance | 14.27 | 19.46 | 22.17 | ||
| Paroxetine [25] | BL | 381 | 392.0 | ||
| T | 387 | 394.5 | |||
| I | – | 393.5 | |||
| T + I | 386 | 396.6 | 393.6 | 396.8 | |
| Distance | 4.69 | 4.86 | 4.78 | ||
In bold - the best fitted model (the lowest distance value)
BL baseline, T terfenadine, I inhibitor
aDDI effect on ion channels calculation method
bOnly QT change reported in the study
cMaximal QT change